SMO and hepatocellular carcinoma: Originally, this molecule was considered to have exclusively inhibitory effects on Smo, which was supported by decreased Hh gene expression in breast cancer and hepatocellular carcinoma (HCC) cells in response to cyclopamine [64,65].